TrialJournal of the American Heart Association2012

Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects.

J Michael Gaziano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.